Articles from Zenflow

Zenflow Secures $52M Series D Financing and Announces Exclusive U.S. Distribution Partnership with Cook Medical
Series D proceeds to support commercialization of the Zenflow Spring® System for Men with Enlarged Prostate
By Zenflow · Via GlobeNewswire · October 5, 2026
Zenflow Announces U.S. Commercialization Progress with Four Centers Completing Zenflow Spring® Implant and Delivery System Procedures
Strong Interest from Surgeons Drives Integration of New First-Line Interventional BPH Treatment Approach
By Zenflow · Via GlobeNewswire · September 8, 2026
Zenflow Presents the BREEZE™ Pivotal Clinical Trial at the American Urological Association Annual Meeting
Data Supported the FDA Approval of the Zenflow Spring® Implant and Delivery System for BPH
By Zenflow · Via GlobeNewswire · May 18, 2026
FDA Approves the Zenflow Spring® Implant and Delivery System for First-Line Interventional Therapy of Patients with Benign Prostatic Hyperplasia (BPH)
Long-Term Data Supports Three-Year Durability
By Zenflow · Via GlobeNewswire · December 11, 2025
Zenflow Receives FDA 510(k) Clearance for First-of-Its-Kind Single-Use Cystoscope
Spring® Scope delivers the largest working channel of any flexible single-use cystoscope, enhancing visualization and patient comfort
By Zenflow · Via GlobeNewswire · September 30, 2025
Three-Year Data of Zenflow’s Spring System Demonstrate Durability of Clinical Benefits for Patients Suffering from BPH
Data Presented at the AUA Meeting Reflect Longest-Term Data among FIT Interventions
By Zenflow · Via GlobeNewswire · April 26, 2025
Articles from Zenflow | MarketMinute